<PAGE>
EXHIBIT 23.1
EXHIBIT 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in this
Registration Statement on Form S-8 of our report dated February 14, 2000
relating to the financial statements of AVANT Immunotherapeutics, Inc., which
appears in AVANT Immunotherapeutics, Inc.'s Annual Report on Form 10-K/A for
the year ended December 31, 1999.
/s/ PricewaterhouseCoopers LLP
------------------------------
PricewaterhouseCoopers LLP
Boston, Massachusetts
December 22, 2000
